Thai Doctors To Begin Beta-Thalassemia Treatment Trials In 2011
This article was originally published in PharmAsia News
Thai researchers expect to begin trials at home this year on gene-therapy technology they have been developing and testing successfully in Paris. The joint research is into a beta-thalassemia blood disorder treatment that has been successful in weaning a Frenchman off a lifetime of transfusions. The Thai researchers involved in the experiment using gene therapy are from Ramathibodi Hospital, which expects to begin a trial in December. An estimated 20 million Thais carry the disorder, now treated with bone-marrow transplants. Click here for more) "Medical Leap Gives Hope To Blood-Disorder Sufferers" - Bangkok Post (Thailand) (1/3/10)
You may also be interested in...
The China National Biotec Group has filed the first application in China for the broad use of a COVID-19 vaccine, days after the national regulatory agency released review guidelines for the conditional approval of such products.
More patent-related turbulence appears ahead for Novartis’s sacubitril/valsartan combination in India, with Torrent emerging as the new challenger. The companies are engaged in a legal battle and the Indian firm is also seeking a revocation of the patent on the star heart failure treatment.
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.